Merck KGaA Stock

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 11:35:06 2024-05-31 am EDT 5-day change 1st Jan Change
166.5 EUR +1.12% Intraday chart for Merck KGaA -0.75% +15.54%
Sales 2024 * 21.3B 23.1B Sales 2025 * 22.59B 24.5B Capitalization 72.39B 78.51B
Net income 2024 * 3.01B 3.26B Net income 2025 * 3.53B 3.83B EV / Sales 2024 * 3.68 x
Net Debt 2024 * 6.09B 6.61B Net Debt 2025 * 4.41B 4.79B EV / Sales 2025 * 3.4 x
P/E ratio 2024 *
24 x
P/E ratio 2025 *
20.4 x
Employees 62,345
Yield 2024 *
1.36%
Yield 2025 *
1.47%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.12%
1 week-0.75%
1 month+11.78%
3 months+5.51%
6 months+3.97%
Current year+15.54%
More quotes
1 week
164.05
Extreme 164.05
171.15
1 month
149.00
Extreme 149
171.15
Current year
140.50
Extreme 140.5
171.15
1 year
134.30
Extreme 134.3
172.40
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
61.05
Extreme 61.05
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 54 19-04-25
Members of the board TitleAgeSince
Director/Board Member 75 14-05-08
Chairman 67 19-04-25
Director/Board Member 61 12-04-30
More insiders
Date Price Change Volume
24-05-31 166.5 +1.12% 568,222
24-05-30 164.6 -2.28% 324,904
24-05-29 168.5 +0.51% 257,213
24-05-28 167.6 +0.15% 136,730
24-05-27 167.4 -0.21% 117,979

Delayed Quote Xetra, May 31, 2024 at 11:35 am EDT

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
166.5 EUR
Average target price
184.8 EUR
Spread / Average Target
+11.00%
Consensus